基于扩散加权成像的非增强MRI方案诊断乳腺癌的性能:系统综述与Meta分析
该系统综述与Meta分析检索PubMed 1985年1月至2023年9月文献,纳入28项研究、3787例患者4406个病灶(1676个恶性、2730个良性),评估基于DWI的非增强MRI方案(ncDWI)诊断乳腺癌的效能。ncDWI汇总敏感度86.5%(95%CI:81.4,90.4)、特异度83.5%(95%CI:76.9,88.6),研究间异质性高(I²分别为81.6%和91.6%,P<.001)。与CE MRI相比,ncDWI敏感度较低(88.9% vs 95.1%,P=.004)、特异度相似(82.0% vs 82.2%,P=.97);与标准乳腺X线摄影相比,ncDWI的SROC曲线下面积更高(0.93 vs 0.78,P<.001)。
要点
- ncDWI诊断乳腺癌汇总敏感度86.5%、特异度83.5%,研究间异质性高(I²=81.6%和91.6%)。
- 与CE MRI相比,ncDWI敏感度较低(88.9% vs 95.1%,P=.004),特异度相似(82.0% vs 82.2%,P=.97)。
- 与乳腺X线摄影相比,ncDWI的SROC曲线下面积更高(0.93 vs 0.78,P<.001)。
核心结论
- 与CE MRI直接比较,ncDWI敏感度略低而特异度相似;ncDWI的诊断性能指标高于标准乳腺X线摄影。
- 研究间异质性高,因此这些结果必须谨慎解读。
研究设计与样本
- 系统综述与Meta分析,检索PubMed 1985年1月至2023年9月发表的文献。
- 排除仅研究恶性病变或仅选择特定患者和/或病灶、将DWI作为CE MRI辅助技术以及技术性研究。
- 共纳入28项研究,3787例患者、4406个病灶(1676个恶性、2730个良性)。
- 统计分析包括汇总诊断准确性并探讨研究间异质性,并进行ncDWI与CE MRI及标准乳腺X线摄影的亚组比较。
诊断标准与关键数值
- ncDWI汇总敏感度86.5%(95%CI:81.4,90.4),汇总特异度83.5%(95%CI:76.9,88.6)。
- ncDWI敏感度异质性I²=81.6%、特异度异质性I²=91.6%(P<.001)。
- CE MRI(18项研究)敏感度95.1%(95%CI:92.9,96.7)vs ncDWI 88.9%(95%CI:82.4,93.1),P=.004;特异度CE MRI 82.2%(95%CI:75.0,87.7)vs ncDWI 82.0%(95%CI:74.8,87.5),P=.97。
- 乳腺X线摄影(5项研究)敏感度80.3%(95%CI:56.3,93.3)vs ncDWI 56.7%(95%CI:41.9,70.4),P=.09;特异度乳腺X线摄影89.9%(95%CI:85.5,93.1)vs ncDWI 90%(95%CI:61.3,98.1),P=.62。
- SROC曲线下面积ncDWI 0.93(95%CI:0.91,0.95)vs 乳腺X线摄影0.78(95%CI:0.74,0.81),P<.001。
临床应用与阅片要点
- 原文结论指出,与CE MRI直接比较,ncDWI敏感度略低而特异度相似,其诊断性能指标高于标准乳腺X线摄影。
- 原文指出研究间异质性高,因此这些结果必须谨慎解读。
局限性
- 敏感度和特异度均呈现高研究间异质性(I²=81.6%和91.6%,P<.001)。
- 原文结论指出异质性高,因此这些结果必须谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Diffusion-weighted imaging (DWI) is increasingly recognized as a powerful diagnostic tool and tested alternative to contrast-enhanced (CE) breast MRI. Purpose To perform a systematic review and meta-analysis that assesses the diagnostic performance of DWI-based noncontrast MRI protocols (ncDWI) for the diagnosis of breast cancer. Materials and Methods A systematic literature search in PubMed for articles published from January 1985 to September 2023 was performed. Studies were excluded if they investigated malignant lesions or selected patients and/or lesions only, used DWI as an adjunct technique to CE MRI, or were technical studies. Statistical analysis included pooling of diagnostic accuracy and investigating between-study heterogeneity. Additional subgroup comparisons of ncDWI to CE MRI and standard mammography were performed. Results A total of 28 studies were included, with 4406 lesions (1676 malignant, 2730 benign) in 3787 patients. The pooled sensitivity and specificity of ncDWI were 86.5% (95% CI: 81.4, 90.4) and 83.5% (95% CI: 76.9, 88.6), and both measures presented with high between-study heterogeneity (I 2 = 81.6% and 91.6%, respectively; P < .001). CE MRI (18 studies) had higher sensitivity than ncDWI (95.1% [95% CI: 92.9, 96.7] vs 88.9% [95% CI: 82.4, 93.1], P = .004) at similar specificity (82.2% [95% CI: 75.0, 87.7] vs 82.0% [95% CI: 74.8, 87.5], P = .97). Compared with ncDWI, mammography (five studies) showed no evidence of a statistical difference for sensitivity (80.3% [95% CI: 56.3, 93.3] vs 56.7%; [95% CI: 41.9, 70.4], respectively; P = .09) or specificity (89.9% [95% CI: 85.5, 93.1] vs 90% [95% CI: 61.3, 98.1], respectively; P = .62), but ncDWI had a higher area under the summary receiver operating characteristic curve (0.93 [95% CI: 0.91, 0.95] vs 0.78 [95% CI: 0.74, 0.81], P < .001). Conclusion A direct comparison with CE MRI showed a modestly lower sensitivity at similar specificity for ncDWI, and higher diagnostic performance indexes for ncDWI than standard mammography. Heterogeneity was high, thus these results must be interpreted with caution. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Kataoka and Iima in this issue.
引用
- Pötsch N, Sodano C, Baltzer PAT, et al. Performance of Diffusion-weighted Imaging-based Noncontrast MRI Protocols for Diagnosis of Breast Cancer: A Systematic Review and Meta-Analysis. Radiology. 2024. PMID: 38771179. doi:10.1148/radiol.232508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。